Chonluten (20mg) is a synthetic short peptide bioregulator supplied as a lyophilized powder for controlled laboratory research, analytical evaluation, and in vitro experimentation. It may be examined in defined research models involving peptide characterization, respiratory epithelial cell systems, and pulmonary cell-signaling pathways.
All observations involving Chonluten must remain limited to the conditions and endpoints of the applicable laboratory model. Experimental findings do not establish clinical efficacy, safety, or suitability for use in humans or animals.
Chonluten is supplied exclusively for laboratory research. It is not a drug, dietary supplement, food, cosmetic, or veterinary product. It is not intended for human or animal consumption, in vivo procedures, diagnostic use, therapeutic use, or the prevention of any disease or condition.
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
Chonluten (20mg) is a synthetic short peptide bioregulator supplied as a lyophilized powder for controlled laboratory research, analytical evaluation, and in vitro experimentation. It may be examined in defined research models involving peptide characterization, respiratory epithelial cell systems, and pulmonary cell-signaling pathways.
All observations involving Chonluten must remain limited to the conditions and endpoints of the applicable laboratory model. Experimental findings do not establish clinical efficacy, safety, or suitability for use in humans or animals.
Chonluten is supplied exclusively for laboratory research. It is not a drug, dietary supplement, food, cosmetic, or veterinary product. It is not intended for human or animal consumption, in vivo procedures, diagnostic use, therapeutic use, or the prevention of any disease or condition.
Chonluten (20mg) – Research Specifications:
| Compound | Chonluten |
| Quantity | 20mg per vial |
| Compound Type | Synthetic short peptide bioregulator |
| Form | Lyophilized powder |
| Purity and Identity | Refer to the lot-specific Certificate of Analysis |
| Analytical Testing | Testing methods and results are documented in the applicable COA |
| Storage Conditions | Store sealed in a cool, dry environment protected from heat, light, and moisture |
| Permitted Use | In vitro laboratory research, analytical evaluation, and controlled scientific experimentation only |
| Restrictions | Not for human or animal consumption, in vivo use, diagnostic use, therapeutic use, food use, cosmetic use, or supplement use |
Chonluten belongs to a category of short synthetic peptides evaluated as laboratory research materials. Research involving this category may examine peptide identity, physicochemical characteristics, stability, and behavior within controlled cellular or biochemical assay systems.
Chonluten is commonly associated with experimental models involving respiratory epithelial biology. In these studies, researchers may measure predefined cellular markers, gene-expression data, peptide interactions, or other analytical endpoints. References to respiratory or pulmonary research describe the design of the laboratory model and do not indicate an intended medical application.
Respiratory epithelial assays can vary significantly according to cell type, culture conditions, analytical method, exposure parameters, and endpoint selection. Results should therefore be interpreted only within the specific experimental framework in which they were generated.
Researchers conducting broader peptide-comparison studies may also evaluate materials such as BPC-157, Thymosin Beta 4, and GHK-CU. Each compound should be evaluated independently using appropriate controls and documented laboratory procedures.
Important Research Notice: Nordsci research materials are accompanied by lot-specific analytical documentation. Researchers should review the applicable Certificate of Analysis before incorporating any material into an experimental workflow.
THIS PRODUCT IS FOR LABORATORY RESEARCH USE ONLY. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR IN VIVO, DIAGNOSTIC, THERAPEUTIC, FOOD, COSMETIC, OR SUPPLEMENT USE.
Chonluten may be included as an experimental variable in controlled in vitro respiratory epithelial cell assays. Researchers can use predefined protocols to measure relevant cellular, biochemical, or gene-expression endpoints under documented laboratory conditions.
Laboratory models examining pulmonary tissue homeostasis may incorporate Chonluten for comparative analytical purposes. The material's role should be limited to the specific assay, controls, and measurable endpoints established in the research protocol.
In vitro airway models may be used to observe selected signaling markers under controlled conditions. Research involving Chonluten should focus on measurable laboratory data without extending findings to immune function, disease outcomes, or clinical applications.
Chonluten may be evaluated in assays designed to measure selected pathway-associated markers. References to cellular pathways identify experimental endpoints only and do not indicate that the material produces regenerative or therapeutic outcomes.
Chonluten (20mg) should be handled by qualified laboratory personnel using established institutional procedures for peptide research materials. Researchers should document the product lot, storage history, environmental conditions, control groups, analytical methods, and predefined endpoints used in each experiment.
Cross-study comparisons should account for differences in assay design, cell models, equipment, sample preparation, and analytical sensitivity. Experimental observations apply only to the conditions under which the data were collected.
No human, veterinary, clinical, diagnostic, or therapeutic application is permitted. No dosing, injection, administration, or consumer-use guidance is provided.
Store Chonluten in its sealed lyophilized form within a cool, dry environment protected from direct light, excessive heat, and moisture. Storage procedures should follow the conditions listed on the product label and applicable lot-specific documentation.
Temperature changes and repeated exposure to ambient moisture may affect research materials. Laboratories should use documented inventory controls and storage-monitoring procedures appropriate to their research protocols.
Each lot of Chonluten supplied by Nordsci Peptides is associated with analytical documentation for laboratory review. The Certificate of Analysis provides the testing information applicable to the individual lot and allows researchers to confirm documented identity and analytical results before use.
Laboratories sourcing Chonluten should evaluate product identification, batch traceability, storage documentation, analytical testing, and access to a lot-specific Certificate of Analysis.
Nordsci Peptides supplies Chonluten (20mg) as a research-use-only material with supporting analytical documentation. Product labeling and documentation should be reviewed before the material is incorporated into any laboratory protocol.
IMPORTANT: Chonluten (20mg) is sold exclusively for laboratory research and analytical use. It is not approved for human or animal consumption, in vivo research, clinical use, diagnostic use, therapeutic use, or use as a drug, food, dietary supplement, or cosmetic.
